Tyrosine phosphatase-2 (SHP2) highly expressed EVs derived from MSCs were utilized to penetrate the blood-brain barrier, induce mitophagy in neuronal cells, and diminish their apoptosis, contributing to the treatment of Alzheimer's disease (AD)[31]. The gene discussed is PTPN11; the disease is Alzheimer disease.